24 results
424B5
TRML
Tourmaline Bio Inc
26 Jan 24
Prospectus supplement for primary offering
4:08pm
) on the net gain derived from the disposition, which may be offset by certain U.S. source capital losses of the non-U.S. holder, if any (even though
424B5
TRML
Tourmaline Bio Inc
24 Jan 24
Prospectus supplement for primary offering
9:20pm
between the United States and such holder’s country of residence) on the net gain derived from the disposition, which may be offset by certain U.S
8-K
EX-99.2
07iug7u8ugs0r52vgj3
24 Jan 24
Results of Operations and Financial Condition
5:10pm
S-4
EX-10.1
n9ug4tpblfl
19 Jul 23
Registration of securities issued in business combination transactions
7:57pm
10-K
snxmn
17 Mar 22
Annual report
4:31pm
10-Q
a9wi6 pjxsfy
14 Jun 21
Quarterly report
4:21pm
424B4
m8m85nj3 5at9fyzzd
10 May 21
Prospectus supplement with pricing info
4:20pm